Geneva, Switzerland

Christian Koller



Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Christian Koller

Introduction

Christian Koller, a distinguished inventor based in Geneva, Switzerland, has made significant contributions to the field of biomedicine through his innovative work. With a total of two patents to his name, Koller has developed groundbreaking technologies that address critical challenges in the realm of selectin targeting.

Latest Patents

Among his latest inventions is the "Recombinant Chimeric Protein for Selectins Targeting." This cutting-edge technology discloses a recombinant protein, designated as PSGL-1-NRL chimeric protein, which consists of a Selectin Binding domain and a non-covalent dimerization domain derived from the Neural Retina-specific Leucine Zipper. The chimeric protein integrates a covalent dimerization domain with a cysteine capable of forming a disulfide bridge with another chimeric protein, facilitating the formation of homodimers. In this composition, the PSGL-1 domain pertains to the extracellular region of Human PSGL-1, representing the selectin binding region of the mature protein. Notably, the chimeric protein is post-translationally modified, efficiently expressed in mammalian systems, and is capable of binding P, E, and L selectin, which is advantageous for both in vivo and in vitro targeting for diagnostic or therapeutic applications.

Career Highlights

Throughout his career, Christian Koller has collaborated with prominent companies such as Bracco Suisse and Bracco Suisse Sa. His innovative approach and expertise in biochemistry have led to advancements in medical technologies that hold promise for therapeutic interventions.

Collaborations

Koller has worked alongside talented peers, including Federico Maisano and Federico Crivellin. These collaborations have fueled innovative ideas and systematically enhanced their collective contributions to the field.

Conclusion

Christian Koller stands out as an inventor whose work has the potential to revolutionize diagnostics and treatment methodologies. His patents, especially the recombinant chimeric protein aimed at selectin targeting, reflect the cutting-edge nature of his contributions to science, underscoring his role as an influential figure in biomedicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…